SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Adams who wrote (12048)2/16/2001 2:19:51 PM
From: TimbaBear  Read Replies (1) of 78471
 
I own CEGE. I bought it at much higher levels than here. I evaluated it recently and got a NetNet valuation of $15.47/share so at current levels it appears to be approaching very comfortable margins of safety. I bought it because of it's portfolio of gene therapy patents and the work it's doing on cancer vaccines. I think it has far more upside potential at these prices than downside. I think the largest portion of cash came from selling part of their ownship in Abgenix. They still retain a substantial interest in that company.

I have gotten burned looking at the comparison of cash on hand to market price. I've gotten more conservative in these times when conservative approaches are bearing fruit.

Timba
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext